Drugs
- Andexanet alfa (Andexxa)
- Apixaban (Eliquis)
- Betrixaban (Bevyxxa)
- Bivalirudin (Angiomax)
- Dabigatran (Pradaxa)
- Edoxaban (Savaysa)
- Fondaparinux (Arixtra)
- Heparin
- Heparin Infusion Guidelines
- Heparin Infusion Algorithms
- MCS Heparin Infusion Algorithms
- New Heparin Protocols - Provider Update
- New Heparin Protocols - Nurse Education
- Monitoring Heparin with PTT Levels
- DOAC to Heparin Transition (UWMC-ML)
- DOAC to Heparin Transition (HMC & UWMC-NW)
- Full Intensity SQ Heparin
- Idarucizumab (Praxbind)
- Low Molecular Weight Heparin (LMWH)
- Rivaroxaban (Xarelto)
- Warfarin (Coumadin)
Conditions
- Monitoring Antithrombotic Therapy
- Anticoaguation and Neuraxial Anesthesia
- Bleeding Risk Assessment
- Central Venous Catheter Management
- Chronic Antithrombotic Therapy
- Guidelines for Reversal of Anticoagulation
- Anticoagulant Reversal for IPH
- Guidelines for Reversal of Anticoagulants
- Head Injury in Anticoagulated Patients
- UW - CT Surgery Perioperative Hemostasis Plan
- Heparin-Induced Thrombocytopenia (HIT)
- Mechanical Circulatory Support
- Peri-Procedural Anticoagulation
- Anticoagulation Around Invasive Procedures
- Anticoagulation Around Dental Procedures
- Management of Antithrombotic Therapy for Chronic Pain Procedures
- Management of Antithrombotic Therapy for Neuraxial Procedures
- Perioperative Management of Antiplatelet Therapy
- VTE
- VTE Prophylaxis
- DVT
- PE
- VTE Treatment
©2014 University of Washington